Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Flagship Pioneering
AddedFeb 13, 2024
UpdatedJul 2, 2026
Flagship Pioneering

Flagship Pioneering

Operating

Flagship Pioneering, Inc., a US-based venture capital firm, invests in pharmaceutical, electronic, and medical sectors.

Location
Cambridge, MA, US
Founded
2000
Firm
Analysis
Compare
Portfolio
Employees
Website

Flagship Pioneering, Inc. is a US-based venture capital firm that focuses on investing in the pharmaceutical, electronic, and medical device sectors. The firm typically engages in Series A through Series E funding rounds, with a strong presence in early to mid-stage investments. Flagship Pioneering is known for its substantial financial backing, often participating in significant funding rounds for innovative companies in its target sectors.

Notable portfolio companies include Moderna, Generate Biomedicines, Indigo Agriculture, and Denali Therapeutics. The firm is led by key decision-makers such as Noubar Afeyan, who is also affiliated with Moderna. Flagship Pioneering emphasizes a pioneering investment philosophy, aiming to create and support transformative companies. They offer unique value-add services such as strategic partnerships, exemplified by their collaboration with Pfizer to develop novel therapeutics for obesity.

Flagship Pioneering - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments130
Current Portfolio Count48
Total Portfolio Exits5

Top Investment Stages

Series A33 (29.2%)
Series B27 (23.9%)
Series Unknown24 (21.2%)
Series C22 (19.5%)
Series D7 (6.2%)

Stage Mix

Series A 29%Series B 24%Series Unknown 21%Series C 19%Series D 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Lila Sciences logo

Lila Sciences

Inari Agriculture logo

Inari Agriculture

Syros Pharmaceuticals logo

Syros Pharmaceuticals

Harbinger Health logo

Harbinger Health

Indigo logo

Indigo

Generate Biomedicines logo

Generate Biomedicines

Alltrna logo

Alltrna

Empress Therapeutics logo

Empress Therapeutics

Metaphore Biotechnologies logo

Metaphore Biotechnologies

Ring Therapeutics logo

Ring Therapeutics

Ampersand Biomedicines logo

Ampersand Biomedicines

Montai Health logo

Montai Health

Cellarity logo

Cellarity

Senda Biosciences logo

Senda Biosciences

Apriori Bio logo

Apriori Bio

ProFound Therapeutics logo

ProFound Therapeutics

Vesalius Therapeutics logo

Vesalius Therapeutics

Cibo Technologies logo

Cibo Technologies

YourBio Health logo

YourBio Health

Laronde logo

Laronde

Invaio Sciences logo

Invaio Sciences

Repertoire Immune Medicines logo

Repertoire Immune Medicines

Valo Health logo

Valo Health

Cygnal Therapeutics logo

Cygnal Therapeutics

KSQ Therapeutics logo

KSQ Therapeutics

Flagship Pioneering - Similar Investment Firms

Pfizer Venture Investments logo

Pfizer Venture Investments

pfizer.com

Kleiner Perkins Caufield & Byers logo

Kleiner Perkins Caufield & Byers

kleinerperkins.com

Atlas Venture logo

Atlas Venture

atlasventure.com

Tech Pioneers Fund logo

Tech Pioneers Fund

Pillar VC logo

Pillar VC

pillar.vc

Founders Fund logo

Founders Fund

foundersfund.com

Precursor Ventures logo

Precursor Ventures

precursorvc.com

Foresite Capital logo

Foresite Capital

Founder Collective logo

Founder Collective

Redpoint Ventures logo

Redpoint Ventures

redpoint.com

FirstMark Capital logo

FirstMark Capital

firstmarkcap.com

Obvious Ventures logo

Obvious Ventures

obvious.com

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

Boutique Venture Partners logo

Boutique Venture Partners

boutiquevc.com

Pivotal bioVenture Partners logo

Pivotal bioVenture Partners

Flagship Pioneering - Classification

Also Known As
  • Flagship Ventures Management, Inc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end